{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:43:30Z","timestamp":1791287010708,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010846","name":"Health and Family Planning Commission of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017958","name":"Health and Family Planning Commission of Hubei Province","doi-asserted-by":"publisher","award":["WJ2022MB216"],"award-info":[{"award-number":["WJ2022MB216"]}],"id":[{"id":"10.13039\/100017958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150653","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:08:07Z","timestamp":1725376087000},"page":"150653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors"],"prefix":"10.1016","volume":"733","author":[{"given":"Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150653_bib1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/ajh.26642","article-title":"Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring","volume":"97","author":"Jabbour","year":"2022","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bbrc.2024.150653_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2024.150653_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12185-018-2519-y","article-title":"Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistence","volume":"108","author":"Inoue","year":"2018","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbrc.2024.150653_bib4","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41375-019-0490-0","article-title":"Chronic myeloid leukemia stem cells","volume":"33","author":"Houshmand","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2024.150653_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/plants9121784","article-title":"Multi-therapeutic potential of naringenin (4',5,7-trihydroxyflavonone): experimental evidence and mechanisms","volume":"9","author":"Arafah","year":"2020","journal-title":"Plants"},{"key":"10.1016\/j.bbrc.2024.150653_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120752","article-title":"Naringenin: a potential flavonoid phytochemical for cancer therapy","volume":"305","author":"Motallebi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2024.150653_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ph12010011","article-title":"The therapeutic potential of naringenin: a review of clinical trials","volume":"12","author":"Salehi","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2024.150653_bib8","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.7150\/ijms.44804","article-title":"Naringenin exerts anticancer effects by inducing tumor cell death and inhibiting angiogenesis in malignant melanoma","volume":"17","author":"Choi","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bbrc.2024.150653_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071686","article-title":"Naringin and naringenin: their mechanisms of action and the potential anticancer activities","volume":"10","author":"Stabrauskiene","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2024.150653_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1406619","article-title":"Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics","volume":"15","author":"Elsori","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150653_bib11","article-title":"Co-Treatment of naringenin and ketoprofen-RGD suppresses cell proliferation via calmodulin\/PDE\/cAMP\/PKA Axis pathway in leukemia and ovarian cancer cells","volume":"22","author":"Afshari","year":"2023","journal-title":"Iran. J. Pharm. Res. (IJPR) : IJPR"},{"key":"10.1016\/j.bbrc.2024.150653_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15826","article-title":"Naringenin induces the cell apoptosis of acute myeloid leukemia cells by regulating the lncRNA XIST\/miR-34a\/HDAC1 signaling","volume":"9","author":"Wen","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2024.150653_bib13","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.3892\/mmr.2015.4480","article-title":"Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways","volume":"12","author":"Shi","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2024.150653_bib14","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/13880209.2022.2044862","article-title":"Stachydrine is effective and selective against blast phase chronic myeloid leukaemia through inhibition of multiple receptor tyrosine kinases","volume":"60","author":"Gu","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.bbrc.2024.150653_bib15","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells","volume":"103","author":"Chu","year":"2004","journal-title":"Blood"},{"issue":"Suppl 3","key":"10.1016\/j.bbrc.2024.150653_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2012.0184","article-title":"Current issues in chronic myeloid leukemia: monitoring, resistance, and functional cure","volume":"10","author":"Cortes","year":"2012","journal-title":"J. Natl. Compr. Cancer Netw. : J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.bbrc.2024.150653_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2024.150653_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10787-018-00556-3","article-title":"Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways","volume":"27","author":"Zhao","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbrc.2024.150653_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155786","article-title":"The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition","volume":"131","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2024.150653_bib20","doi-asserted-by":"crossref","DOI":"10.1049\/2024\/3786627","article-title":"Liposomal-naringenin radiosensitizes triple-negative breast cancer MDA-MB-231 cells in vitro","volume":"2024","author":"Pearce","year":"2024","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.bbrc.2024.150653_bib21","article-title":"Naringenin enhances the efficacy of ferroptosis inducers by attenuating aerobic glycolysis by activating the AMPK-PGC1alpha signalling axis in liver cancer","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2024.150653_bib22","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1007\/s11033-023-08664-2","article-title":"Naringenin in combination with quercetin\/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines","volume":"50","author":"Jalalpour Choupanan","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbrc.2024.150653_bib23","article-title":"Synergism antiproliferative effects of apigenin and naringenin in NSCLC cells","volume":"28","author":"Liu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2024.150653_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ph16070921","article-title":"The potential protective role of naringenin against dasatinib-induced hepatotoxicity","volume":"16","author":"Alanazi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2024.150653_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpc.2020.108969","article-title":"Biochemical changes and antioxidant capacity of naringin and naringenin against malathion toxicity in Saccharomyces cerevisiae","volume":"241","author":"Gercek","year":"2021","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150653_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nutres.2023.08.006","article-title":"Biological activities of naringenin: a narrative review based on in vitro and in vivo studies","volume":"119","author":"Ucar","year":"2023","journal-title":"Nutr. Res."},{"key":"10.1016\/j.bbrc.2024.150653_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.7150\/ijbs.85443","article-title":"Promotion of ROS-mediated apoptosis, G2\/M arrest, and autophagy by naringenin in non-small cell lung cancer","volume":"20","author":"Chang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2024.150653_bib28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/0115680096267430231023091521","article-title":"Naringenin-induced oral cancer cell apoptosis via ROS-mediated bid and bcl-xl signaling pathway","volume":"24","author":"Du","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2024.150653_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12032-023-02227-y","article-title":"Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3","volume":"41","author":"Ramya Devi","year":"2023","journal-title":"Med. Oncol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24011896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24011896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:53:16Z","timestamp":1733320396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24011896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"alternative-id":["S0006291X24011896"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150653","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150653"}}